Home
Hidradenitis Suppurativa
NOD2 signalling in hidradenitis suppurativa
Extracellular matrix graft for the surgical management of Hurley stage III hidradenitis suppurativa: a pilot case series
Trends in Body Mass Index Before and After Diagnosis of Hidradenitis Suppurativa
Hidradenitis Suppurativa and Atopic Dermatitis: A Two-Way Association
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa; results of a prospective European cohort study
Activity and components of the G-CSF pathway in hidradenitis suppurativa
Differential Profiles of Gamma-Secretase-Notch Signaling in Hidradenitis Suppurativa: The Need for Genotype-Endotype-Phenotype Analysis
Drug survival of Adalimumab and Infliximab in Hidradenitis Suppurativa Patients: A Daily Practice Cohort Study
Hepatitis B and C among patients with hidradenitis suppurativa: a population-based study
Comorbidity screening in Hidradenitis Suppurativa: evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations
1
…
3
4
5
×